In 73 healthy volunteers in an open phase 1 trial of linaprazan glurate (25–75 mg once or twice daily for 14 days), 50 mg and 75 mg twice daily held gastric pH >4 for >90% of Day 1 and >95% of Day 14; exposure rose roughly in proportion to dose.
RCTn = 73
Larsson et al. Clinical trial: The Effect on Intragastric pH and Pharmacokinetics of the PCAB Linaprazan Glurate in Healthy Subjects After Repeat-Dose Administration for up to 14 Days